Headline News about Hutchmed China Ltd ADRVia Benzinga
HUTCHMED Out Licenses Fruquintinib To Takeda Outside China
January 23, 2023
Via Benzinga
Hutchmed Plans Strategic Focus Shift On Late-Stage Programs, Details Not Disclosed
November 15, 2022
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 07, 2023
Via Benzinga
Via Benzinga
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 08, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|